Sage Therapeutics to Present at Upcoming September Investor Conferences
- S&P 500 ends lower on mixed Fed messages, PCE on deck
- Salesforce lifts annual guidance after Q3 earnings beat expectations; stock jumps
- Economic outlook deteriorates as growth, inflation slows: Fed's Beige Book
- UAW push to organize Tesla (TSLA) and non-union auto sector
- After-hours movers: Salesforce, Snowflake jump on strong results
CAMBRIDGE, Mass.--(BUSINESS WIRE)-- Sage Therapeutics, Inc. (NASDAQ: SAGE), a biopharmaceutical company leading the way to create a world with better brain health, announced today that the Company will present at the following upcoming investor conferences in September:
- Morgan Stanley 21st Annual Global Healthcare Conference (New York, NY): fireside chat on Wednesday, September 13, 2023 at 12:15 p.m. ET.
- TD Cowen 3rd Annual Novel Mechanisms in Neuropsychiatry Summit (Virtual): fireside chat on Wednesday, September 20, 2023 at 3:00 p.m. ET.
A live webcast of each event can be accessed on the Investor page of Sage’s website at investor.sagerx.com. A replay of the webcasts will be available following the completion of the event and will be archived for up to 30 days.
About Sage Therapeutics
Sage Therapeutics is a biopharmaceutical company fearlessly leading the way to create a world with better brain health. Our mission is to pioneer solutions to deliver life-changing brain health medicines, so every person can thrive. For more information, please visit www.sagerx.com.
Source: Sage Therapeutics, Inc.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fujirebio and Sysmex Expand CDMO Partnership into the Field of Neurodegenerative Diseases under Their Immunoassay Collaboration
- ESI Group: PRESS RELEASE OF NOVEMBER 30 2023
- Technip Energies and John Cockerill Reach Closing of Rely, a New Company Dedicated to Integrated Green Hydrogen and Power-to-X Solutions
Create E-mail Alert Related CategoriesBusiness Wire, Press Releases
Related EntitiesMorgan Stanley, Cowen & Co
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!